Sepsis-associated acute kidney injury : recent advances in enrichment strategies, sub-phenotyping and clinical trials
© 2024. The Author(s)..
Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome. We discuss lessons learned and potential opportunities to improve the design of clinical trials and generate actionable evidence in future research. We specifically discuss the role of enrichment strategies to target populations that are most likely to derive benefit and the importance of patient-centered clinical trial endpoints and appropriate trial designs with the aim to provide guidance in designing future trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Critical care (London, England) - 28(2024), 1 vom: 21. März, Seite 92 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Legrand, Matthieu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 05.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13054-024-04877-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370046986 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370046986 | ||
| 003 | DE-627 | ||
| 005 | 20240406232343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13054-024-04877-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM370046986 | ||
| 035 | |a (NLM)38515121 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Legrand, Matthieu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sepsis-associated acute kidney injury |b recent advances in enrichment strategies, sub-phenotyping and clinical trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 05.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome. We discuss lessons learned and potential opportunities to improve the design of clinical trials and generate actionable evidence in future research. We specifically discuss the role of enrichment strategies to target populations that are most likely to derive benefit and the importance of patient-centered clinical trial endpoints and appropriate trial designs with the aim to provide guidance in designing future trials | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Bagshaw, Sean M |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatraju, Pavan K |e verfasserin |4 aut | |
| 700 | 1 | |a Bihorac, Azra |e verfasserin |4 aut | |
| 700 | 1 | |a Caniglia, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Khanna, Ashish K |e verfasserin |4 aut | |
| 700 | 1 | |a Kellum, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Koyner, Jay |e verfasserin |4 aut | |
| 700 | 1 | |a Harhay, Michael O |e verfasserin |4 aut | |
| 700 | 1 | |a Zampieri, Fernando G |e verfasserin |4 aut | |
| 700 | 1 | |a Zarbock, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Chung, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Ravindra |e verfasserin |4 aut | |
| 700 | 1 | |a Pickkers, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Ryan, Abigail |e verfasserin |4 aut | |
| 700 | 1 | |a Bernholz, Juliane |e verfasserin |4 aut | |
| 700 | 1 | |a Dember, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Gallagher, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Rossignol, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Ostermann, Marlies |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical care (London, England) |d 1997 |g 28(2024), 1 vom: 21. März, Seite 92 |w (DE-627)NLM097399787 |x 1466-609X |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:1 |g day:21 |g month:03 |g pages:92 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13054-024-04877-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2024 |e 1 |b 21 |c 03 |h 92 | ||